Sequential rapid oral desensitization to rifampin and moxifloxacin for the treatment of active mycobacterium tuberculosis.
Sequential rapid oral desensitization to rifampin and moxifloxacin for the treatment of active mycobacterium tuberculosis. J Allergy Clin Immunol Pract. 2017 Jan - Feb; 5(1):195-197.